Search for: "C & S U.S.A., INC."
Results 161 - 180
of 220
Sorted by Relevance
|
Sort by Date
8 Jan 2010, 12:22 am
See Chevron U.S.A., Inc. v. [read post]
22 Apr 2014, 5:20 am
” § 3142(c)(1) (emphasis added). [read post]
27 Jun 2015, 2:50 pm
This would not merely be an affirmative defense against the breach-of-contract claim as to the lawyer's or lawfirm's fees, but a counter-claim for damages, i.e. a claim by the client against the lawyer that is subject to arbitration. [read post]
11 Aug 2011, 1:09 pm
This precedent includes decades-old cases, e.g., Women’s Health Network, Inc. v. [read post]
28 Jun 2022, 10:04 am
This separate writing is to note my concern with the way in which the Court's opinion in Chevron U.S.A. [read post]
26 Oct 2009, 6:25 am
How much money a ‘patent troll’ makes (The Prior Art) Hospital TTO takes a different path to commercialisation with private sale of IP (Technology Transfer Tactics) US Patents – Decisions CAFC: Attendance at single trade show to display infringing product sufficient for personal jurisdiction: Synthes (U.S.A.) v G.M. [read post]
22 Jul 2014, 7:30 am
Furthermore, the court held that even if the ACA were ambiguous, the IRS’s regulation would represent a permissible construction entitled to deference under Chevron U.S.A., Inc. v. [read post]
17 Jul 2009, 11:33 am
CV-S-05-0610-KJD-LRL (D. [read post]
1 Aug 2011, 2:24 pm
§§ 1.552(c), 1.906(c). [read post]
14 Oct 2016, 2:02 pm
Proposed 28 CFR § 44.101(c) would provide a new definition of the phrase “citizenship status” found in Immigration and Nationality Act (INA) § 274B [codified at 8 U.S.C. [read post]
2 Jul 2012, 11:57 am
On June 28, 2012, the Third Circuit became the first Federal court of appeals to address the secondary payer rights of Medicare Advantage Organizations (also known as Medicare Part C plans). [read post]
2 Jul 2012, 11:57 am
On June 28, 2012, the Third Circuit became the first Federal court of appeals to address the secondary payer rights of Medicare Advantage Organizations (also known as Medicare Part C plans). [read post]
2 Jan 2013, 3:17 pm
Carl’s Patio, Inc. [read post]
26 Feb 2011, 3:47 pm
Prods., Inc. v. [read post]
13 Jul 2021, 3:00 am
Chevron U.S.A. [read post]
26 May 2015, 7:42 am
The ideal defendant’s case might occur in several ways: similar biomarker evidence would point a finger at a purely genetic cause or at some other (perhaps voluntary or non-anthropogenic) exposure; or, a person exposed to a toxin known to cause the person's disease in susceptible people might have a gene that completely neutralized the toxic effect and also might lack a biomarker that is uniformly found in people whose disease was caused by exposure.Steve… [read post]
26 Feb 2015, 5:00 am
Merrell-Dow Pharmaceuticals, Inc., 523 A.2d 374 (Pa. [read post]
8 Oct 2017, 10:12 am
Wyrick, C. [read post]
